65,437 trials
Hereditary Angioedema
Primary: Number of Participants With Adverse Events in Self-treatment of Acute HAE Attacks With s.c. Injections of Icatibant — 11; 6; 27 participants
Cervical Cancer
Primary: Anti-tumor Activity as Measured by Surviving Progression-free — 59 percentage of participants
Cryptogenic Symptomatic Transient Ischemic Attack · Cryptogenic Ischemic Stroke
Primary: AF Detection Rate Within 6 Months — 8.9; 1.4 percentage of participants — p=0.0006
Paroxysmal Atrial Fibrillation
Primary: Atrial Tachyarrhythmia Recurrence in Participants — 37 participants
Neisseria Meningitidis · Haemophilus Influenzae Type b
Primary: Number of Seroprotected Subjects for Anti-polyribosylribitol Phosphate (Anti-PRP). — 108; 111 Participants
Chronic Periodontitis
Primary: Change in Periodontal Inflammation Surface Area (PISA) — 638.16; 288.72 square millimeters
Gingivitis
Primary: Gingival Severity Index (GSI) Based on the Gingival Index (GI) — 0.152; 0.143; 0.212 Units on a scale — p=<0.0001
Non-Constipation Irritable Bowel Syndrome
Primary: Proportion of Subjects Who Had Adequate Relief of Global IBS Symptoms for at Least 2 of the 4 Weeks During the Primary Evaluation Period (ie, Weeks 3 Through 6). — 31.2…
Asthma
Primary: Change From Baseline to Visit 4 in the Mean Daily Composite Score Based on the Pediatric Asthma Caregiver Assessments (PACA) — -1.21; -0.67; -0.52 units on a scale
Anemia, Aplastic · Red-Cell Aplasia, Pure · Anemia, Diamond-Blackfan
Primary: Response to Rituximab — 0; 2; 9 participants
Non-Constipation Irritable Bowel Syndrome
Primary: Proportion of Subjects Who Had Adequate Relief of Global IBS Symptoms for at Least 2 of the 4 Weeks During the Primary Evaluation Period (ie, Weeks 3 Through 6). — 32.2…
Chronic Kidney Disease · Dialysis · Hyperphosphatemia
Primary: The Change in Serum Phosphorus From Week 12 to Week 16 — -0.04; 0.71 mg / dL
Type 1 Diabetes Mellitus
Primary: Early Insulin Exposure (%AUC[0-60]), Stage 1 — 20.99; 34.94; 32.83; 50.97 Percentage of AUC(0-360) — p=0.0009
Renal Transplantation
Primary: Area Under the Curve (AUC) of CD25 Saturation by Basiliximab From Day 0 to Day 84 — 8.4; 11.1; 9.7 Weeks * Percentage of saturated CD25
Trichotillomania · Hair Pulling
Primary: Massachusetts General Hospital Hair Pulling Scale (MGH-HPS) — 10.70; 13.53 units on a scale